GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
#GFN25 Science Lab Discussions #3 | Conversion of glycerol to aldehydes using a vaping device
In this presentation, Sebastian Soulet discusses the chemical processes involved in the conversion of glycerol to aldehydes during vaping. He explains how boiling regimes influence chemical reactions, nicotine delivery, and vaporization efficiency, as well as their toxicological implications.
In this presentation, Paweł Woźnicki, Research & Development Specialist at ChemNovatic, explains the scientific process of removing aroma compounds from nicotine extract. The talk highlights ChemNovatic’s commitment to product purity and technological innovation through their proprietary STC manufacturing standard.
Woźnicki discusses: - advanced purification methods for nicotine; - strategies for identifying and reducing trace impurities; - analytical techniques that ensure the highest product quality; - the importance of maintaining strict production standards in the nicotine industry.
This session offers an in-depth look into modern purification technologies and showcases how science drives product safety and consistency in nicotine manufacturing.
📅 20 Oct 2025
GFN News #161 | ARE BELGIAN VAPE LAWS HELPING OR HURTING PUBLIC HEALTH?
Belgium is rapidly tightening its vaping and smoking rules — from banning disposable e-cigarettes in January 2025 to prohibiting outdoor smoking and vaping on terraces from 2027, and removing smoking rooms in bars, airports, and shisha lounges. In this interview, Joanna speaks with Alberto Gómez Hernández, Policy Manager at the World Vapers’ Alliance, about what’s changing, why it’s happening, and whether these measures.
GFN Voices 2025 #15 | HOW CANADA IS FIGHTING FOR TOBACCO HARM REDUCTION?
Maria Papaioannoy-Duic, founder and spokesperson of Rights for Vapers, speaks with Joanna Junak about the challenges Canadian vapers face in being heard in public health debates. Maria shares how her organization has worked tirelessly to educate consumers on safer nicotine alternatives, fight misinformation, and give a voice to those seeking harm reduction over prohibition.
📅 15 Oct 2025
#GFN25 Panel Discussion | Who else should be in the room?
Extending THR into other disciplines and communities, is essential. Obvious targets are in the fields of drug use and mental health - evidence is clear concerning levels of smoking and associated health risks - but there is need to engage more widely. The panel addressed the barriers to extending reach, including how can we dispel myths and tackle miscommunication? What role does the media have in the process? Who are the key opinion leaders and groups, what are the initial steps in reaching out and how can we support ongoing dialogue?
Get an in-depth look at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (FCTC) Conference, scheduled for November 2025 in Geneva. This video explores the registration process for attending the conference, the challenges faced by harm reduction groups, and the importance of consumer representation in tobacco and nicotine policy discussions.
Welcome to the Science Lab session hosted by Karin Jacobson from JTI Geneva. In this presentation, Anna Masser from Swedish Match discusses nicotine content and nicotine uptake in cigarettes and nicotine pouches, comparing their delivery methods, uptake rates, and how they are used both in clinical settings and real life.
The video covers: - Differences between nicotine delivery in cigarettes vs. nicotine pouches - Standardized clinical testing protocols for nicotine uptake - Pharmacokinetic profiles and plasma nicotine concentration over time - Real-world use comparison of nicotine pouches and cigarettes - Insights into nicotine metabolism and cotinine levels - Discussion on regulated nicotine limits and product risk profiles - Audience Q&A addressing nicotine kinetics and product comparisons
📅 7 Oct 2025
GFN News #159 | VAPING ER “SURGE”: What The Data Really Shows?
GFN News speaks with Filter’s Will Godfrey about reports of dramatic increases in vaping-related emergency department visits across several US states, especially among youth, and examines what those numbers truly represent beyond the headlines. The conversation highlights how headlines like “teen ER visits surge” can obscure distinctions between acute nicotine toxicity and far more subjective “e‑cigarette dependence” admissions that have driven much of the increase in reported cases. The discussion also explores how clinicians may mark visits as vape-related simply because a patient discloses vaping, even when it’s incidental to the medical issue, potentially inflating counts without reflecting actual vaping-caused harm.
Toxicologist Autumn Bernal explains why harm reduction keeps her in the fight: reducing disease burden for adult smokers through better product design, rigorous toxicology, and clear science communication. She highlights the core engineering challenge for ENDS: optimizing heating to minimize emissions while effectively delivering nicotine - without the harmful constituents found in cigarettes.
📅 1 Oct 2025
GFN Voices 2025 #13 | HOW TO CUT TOBACCO HARM IN LMICs?
Challenging misconceptions can save lives. Too often, outdated beliefs and misinformation prevent people from accessing safer alternatives to cigarettes. Today, Dr. Sud Patwardhan sheds light on how evidence-based strategies can help cut tobacco-related harm, especially in low- and middle-income countries where the burden of smoking is highest.
